PTHrP analogue
Abaloparatide dose
Answer
FDA label for Tymlos: Recommended dosage is 80 mcg subcutaneously once daily; patients should receive supplemental calcium and vitamin D if dietary intake is inadequate. Trials with posted results tested 4 doses, most often 80 mcg, 100 mcg, 50 mcg.
Not dosing advice.
FDA LABEL
What the approved labels state
Tymlos NDA208743 · label of 2026-08-11 Regulator
Recommended dosage is 80 mcg subcutaneously once daily; patients should receive supplemental calcium and vitamin D if dietary intake is inadequate.
IN TRIALS
Doses tested in 11 trials with posted results
| Dose in the arm title | Trials | People on it | Phases |
|---|---|---|---|
| 80 mcg | 2 | 873 | 2/3 |
| 100 mcg | 1 | 51 | 2 |
| 50 mcg | 1 | 50 | 2 |
| 150 mcg | 1 | 47 | 2 |
Trial register Read from the titles of arms that received Abaloparatide (n ≥ 20). An arm naming several doses counts under each; a schedule or escalation is on the trial record. All trials.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.